1. Liu, Yalin, Chen, Peng, Hu, Biao, Tu, Manli, Cai, Guangping. 2024. Excessive mechanical loading promotes osteoarthritis development by upregulating Rcn2. In Biochimica et biophysica acta. Molecular basis of disease, 1870, 167251. doi:10.1016/j.bbadis.2024.167251. https://pubmed.ncbi.nlm.nih.gov/38795835/
2. Mei, Chengjie, Jiang, Xiang, Gu, Yang, Zhang, Zhonglin, Yuan, Yufeng. 2021. YY1-mediated reticulocalbin-2 upregulation promotes the hepatocellular carcinoma progression via activating MYC signaling. In American journal of cancer research, 11, 2238-2251. doi:. https://pubmed.ncbi.nlm.nih.gov/34094681/
3. Li, Jing, Cechova, Sylvia, Wang, Lina, Le, Thu H, Shi, Weibin. 2019. Loss of reticulocalbin 2 lowers blood pressure and restrains ANG II-induced hypertension in vivo. In American journal of physiology. Renal physiology, 316, F1141-F1150. doi:10.1152/ajprenal.00567.2018. https://pubmed.ncbi.nlm.nih.gov/30943068/
4. Wardaszka, Patrycja, Soczewka, Piotr, Sienko, Marzena, Zoladek, Teresa, Kaminska, Joanna. 2021. Partial Inhibition of Calcineurin Activity by Rcn2 as a Potential Remedy for Vps13 Deficiency. In International journal of molecular sciences, 22, . doi:10.3390/ijms22031193. https://pubmed.ncbi.nlm.nih.gov/33530471/
5. Chang, Zhihui, Yan, Guangxin, Yan, Hankun, Zheng, Jiahe, Liu, Zhaoyu. 2019. Reticulocalbin 2 enhances osteogenic differentiation of human vascular smooth muscle cells in diabetic conditions. In Life sciences, 233, 116746. doi:10.1016/j.lfs.2019.116746. https://pubmed.ncbi.nlm.nih.gov/31401313/
智鼠故事 
